Open Access. Powered by Scholars. Published by Universities.®

Medicine and Health Sciences Commons

Open Access. Powered by Scholars. Published by Universities.®

2010

Book Gallery

RNA, Small Interfering

Articles 1 - 3 of 3

Full-Text Articles in Medicine and Health Sciences

Oncolog Volume 55, Number 09, September 2010, Sunita Patterson, John Lebas Sep 2010

Oncolog Volume 55, Number 09, September 2010, Sunita Patterson, John Lebas

OncoLog MD Anderson's Report to Physicians (All issues)

  • Tiny Particales, vast Potential-Coming soon to the clinic: nanoparticles that deliver therapy straight to tumor cells, bypassing normal cells and many toxic effects
  • Non-Hodgkin Lymphomas: Targeted Therapies Leading Treatment Advances
  • HOUSE CALL: Writing for Wellness: Keeping a Journal
  • INBRIEF: Study Shows Abnormal Cells in Blood Increase with Lung Cancer Stage


Oncolog Volume 55, Number 04-05, April-May 2010, John Lebas, Sunni Hoseman Apr 2010

Oncolog Volume 55, Number 04-05, April-May 2010, John Lebas, Sunni Hoseman

OncoLog MD Anderson's Report to Physicians (All issues)

  • IMAGING NERVES: Tetnus Toxin Offers Promise for Neurography
  • INBRIEF: Fight-or-Flight Hormones Linked to Metastasis/Drug Combination Shows Promise for Colon Cancer Chemoprevention
  • Compass Spring 2010: Early Uterine Papillary Serous Carcinoma: Treatment Options Tailored to Patient and Disease Characteristcs
  • House Call: Addressing the Cosmetic Effects of Breast Cancer


Oncolog Volume 55, Number 02, February 2010, Joe Munch, John Lebas Feb 2010

Oncolog Volume 55, Number 02, February 2010, Joe Munch, John Lebas

OncoLog MD Anderson's Report to Physicians (All issues)

  • Risk-Based Cancer Screening: M.D. Anderson's revised guidelines offer more precise individualized recommendations on screening for common cancers.
  • Screen Guidelines INBRIEF
  • Electronic Navigatin Biopsy for Peripheral Lung Lesion Diagnosis
  • House Call: Couples and Cancer: Cancer-Related Issues Can Disrupt Relationships
  • INBRIEF: Researchers Find Glioblastoma's Resistance to Treatment Rooted in Immunosuppression